高盛-爱博医疗(688050.SS):业绩回顾:2026年上半年收入超预期但净利润不及预期,目标价下调至52元,评级中性-Eyebright(688050.SS):Earnings review:1H26 revenue beat while NP miss;TP down to Rmb52;Neutral-20260826【7页】

发表回复

后才能评论